S-1/A//SEC Filing
Elixir Pharmaceuticals, Inc. S-1/A
Accession 0001193125-08-002449
CIK 0001175784other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:20 PM ET
Size
847.2 KB
Accession
0001193125-08-002449
Documents
- S-1ds1a.htm
AMENDMENT #5 TO FORM S-1
- EX-1.1dex11.htm
UNDERWRITING AGREEMENT
- EX-10.38dex1038.htm
LICENSE AGREEMENT WITH BRISTOL-MYERS SQUIBB COMPANY
- EX-10.39dex1039.htm
EXCLUSIVE LICENSE AGREEMENT ON MITIGLINIDE WITH KISSEI PHARMACEUTICAL CO. LTD
- EX-10.41dex1041.htm
BINDING AGREEMENT BETWEEN NOVARTIS INTERNATIONAL PHARMACEUTICALS AND ELIXIR PHAR
- EX-23.1dex231.htm
CONSENT OF ERNST & YOUNG LLP
- GRAPHICg21963image001.jpg
GRAPHIC
Issuer
Elixir Pharmaceuticals, Inc.
CIK 0001175784
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001175784
Filing Metadata
- Form type
- S-1/A
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:20 PM ET
- Size
- 847.2 KB